Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy Article (Faculty180)

cited authors

  • Freifeld, Yuval; Ghandour, Rashed; Singla, Nirmish; Woldu, Solomon; Bagrodia, Aditya; Lotan, Yair; Rapoport, Leonid M; Gazimiev, Magomet; Delafuente, Karen; Kulangara, Rohan; Robyak, Haley; Petros, Firas G; Raman, Jay D; Matin, Surena F; Margulis, Vitaly

description

  • Single, postoperative instillation of prophylactic intravesical chemotherapy (pIVC) is effective in reducing bladder cancer recurrences following radical nephroureterectomy (RNU). Despite high level evidence, pIVC is underutilized. Intraoperative pIVC (I-pIVC) may be easier and safer to implement than postoperative pIVC (P-pIVC). We aimed to evaluate the efficacy of I-pIVC during RNU.

authors

publication date

  • 2020

published in

start page

  • 737.e11

end page

  • 737.e16

volume

  • 38